Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Endourology
|
June 15, 2024
Artificial Intelligence in Endourology: Maximizing the Promise Through Consideration of the Principles of Diffusion of Innovation Theory
Manoj Monga, Natalie C Edwards, Sirikan Rojanasarot, et al.
American Journal of Men'S Health
|
October 13, 2020
Addressing Health-Care System Inequities in the Management of Erectile Dysfunction: A Call to Action
Arthur L Burnett, Natalie C Edwards, Tonya M Barrett, et al.
Sexual Medicine Reviews
|
November 4, 2021
The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective
Tung-Chin Hsieh, Natalie C Edwards, Samir K Bhattacharyya, et al.
Pharmacoeconomics
|
April 20, 2005
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US
Natalie C Edwards, Marcia F T Rupnow, Chris L Pashos, et al.
BMC Neurology
|
July 16, 2020
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, et al.
Current Medical Research and Opinion
|
October 29, 2008
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
Natalie C Edwards, Jacqueline Pesa, Dennis M Meletiche, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 11, 2009
Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis
Lawrence D D Goldberg, Natalie C Edwards, Contessa Fincher, et al.
International Journal of MS Care
|
September 18, 2023
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review
Aliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
July 7, 2022
Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Rafael V Lippert, A Zarina Kraal, Natalie C Edwards, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Endourology
|
June 15, 2024
Artificial Intelligence in Endourology: Maximizing the Promise Through Consideration of the Principles of Diffusion of Innovation Theory
Manoj Monga, Natalie C Edwards, Sirikan Rojanasarot, et al.
American Journal of Men'S Health
|
October 13, 2020
Addressing Health-Care System Inequities in the Management of Erectile Dysfunction: A Call to Action
Arthur L Burnett, Natalie C Edwards, Tonya M Barrett, et al.
Sexual Medicine Reviews
|
November 4, 2021
The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective
Tung-Chin Hsieh, Natalie C Edwards, Samir K Bhattacharyya, et al.
Pharmacoeconomics
|
April 20, 2005
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US
Natalie C Edwards, Marcia F T Rupnow, Chris L Pashos, et al.
BMC Neurology
|
July 16, 2020
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, et al.
Current Medical Research and Opinion
|
October 29, 2008
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
Natalie C Edwards, Jacqueline Pesa, Dennis M Meletiche, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 11, 2009
Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis
Lawrence D D Goldberg, Natalie C Edwards, Contessa Fincher, et al.
International Journal of MS Care
|
September 18, 2023
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review
Aliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
July 7, 2022
Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Rafael V Lippert, A Zarina Kraal, Natalie C Edwards, et al.
Page
of 4